1. Home
  2. SELX vs LNAI Comparison

SELX vs LNAI Comparison

Compare SELX & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SELX

Semilux International Ltd. Ordinary Shares

BUY

Current Price

$0.35

Market Cap

11.3M

Sector

N/A

ML Signal

BUY

Logo Lunai Bioworks Inc.

LNAI

Lunai Bioworks Inc.

HOLD

Current Price

$2.54

Market Cap

11.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SELX
LNAI
Founded
2021
N/A
Country
Taiwan
United States
Employees
N/A
29
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3M
11.7M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
SELX
LNAI
Price
$0.35
$2.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.8M
611.7K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.15
52 Week High
$1.48
$3.38

Technical Indicators

Market Signals
Indicator
SELX
LNAI
Relative Strength Index (RSI) 52.65 70.04
Support Level $0.34 $0.93
Resistance Level $0.46 N/A
Average True Range (ATR) 0.07 0.26
MACD 0.02 0.13
Stochastic Oscillator 36.18 72.80

Price Performance

Historical Comparison
SELX
LNAI

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: